|
Randomized surgical multicenter trial to evaluate the usefulness of lymphoscintigraphy (LSG) prior to sentinel node biopsy (SLNB) in early breast cancer: SenSzi (GBG80) trial. |
| |
|
Honoraria - Amgen; Celgene; Genomic Health; Novartis; Roche |
Consulting or Advisory Role - Roche |
|
Travel, Accommodations, Expenses - Celgene; Roche |
| |
|
Travel, Accommodations, Expenses - Celgene |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - AstraZeneca; Celgene; Roche Pharma AG |
Consulting or Advisory Role - Roche |
Travel, Accommodations, Expenses - Celgene; Roche; Teva |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Speakers' Bureau - Genomic Health |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst); Vifor Pharma (Inst) |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Genomic Health; Novartis; Roche |
Consulting or Advisory Role - Genomic Health; Novartis |
Speakers' Bureau - Genomic Health; Novartis; Roche |
Travel, Accommodations, Expenses - Roche |